SUN PHARMACEUTICAL INDUSTRIES - stock earnings
SUNPHARMA.BO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 25.2 billion INR | 121.6 billion INR |
| 2023Q3 | 23.8 billion INR | 120.0 billion INR |
| 2023Q2 | 20.2 billion INR | 117.9 billion INR |
| 2023Q1 | 19.8 billion INR | 107.3 billion INR |
| 2022Q4 | 21.7 billion INR | 111.0 billion INR |
| 2022Q3 | 22.6 billion INR | 108.1 billion INR |
| 2022Q2 | 20.6 billion INR | 106.4 billion INR |
| 2022Q1 | 20.2 billion INR | 106.4 billion INR |
| 2021Q4 | 20.6 billion INR | 98.1 billion INR |
| 2021Q3 | 20.5 billion INR | 95.6 billion INR |
| 2021Q2 | 14.4 billion INR | 96.7 billion INR |
| 2021Q1 | 8.9 billion INR | 84.3 billion INR |
| 2020Q4 | 18.5 billion INR | 87.8 billion INR |
| 2020Q3 | 18.1 billion INR | 84.6 billion INR |
| 2020Q2 | -16.6 billion INR | 74.7 billion INR |
| 2020Q1 | 4.0 billion INR | 80.8 billion INR |
| 2019Q4 | 9.1 billion INR | 80.4 billion INR |
| 2019Q3 | 10.6 billion INR | 79.5 billion INR |
| 2019Q2 | 13.9 billion INR | 82.6 billion INR |
| 2019Q1 | 6.4 billion INR | 70.4 billion INR |
| 2018Q4 | 12.4 billion INR | 76.6 billion INR |
| 2018Q3 | -2.2 billion INR | 68.5 billion INR |
| 2018Q2 | 9.8 billion INR | 71.4 billion INR |
| 2018Q1 | 13.1 billion INR | 67.1 billion INR |
| 2017Q4 | 3.7 billion INR | 66.0 billion INR |
| 2017Q3 | 9.1 billion INR | 65.9 billion INR |
| 2017Q2 | -4.2 billion INR | 61.7 billion INR |
| 2017Q1 | 12.2 billion INR | 68.3 billion INR |
| 2016Q4 | 14.7 billion INR | 76.8 billion INR |
| 2016Q3 | 22.4 billion INR | 77.6 billion INR |
| 2016Q2 | 20.3 billion INR | 80.1 billion INR |
| 2016Q1 | 17.1 billion INR | 74.1 billion INR |
| 2015Q4 | 14.2 billion INR | 70.5 billion INR |
| 2015Q3 | 11.1 billion INR | 68.0 billion INR |
| 2015Q2 | 4.8 billion INR | 65.2 billion INR |
| 2015Q1 | 8.9 billion INR | 61.0 billion INR |
| 2014Q4 | 14.3 billion INR | 42.8 billion INR |
| 2014Q3 | 15.7 billion INR | 47.5 billion INR |
| 2014Q2 | 13.9 billion INR | 39.3 billion INR |
| 2014Q1 | 15.2 billion INR | 40.4 billion INR |
| 2013Q4 | 15.3 billion INR | 42.9 billion INR |
| 2013Q3 | 13.6 billion INR | 41.9 billion INR |
| 2013Q2 | -12.8 billion INR | 34.8 billion INR |
| 2013Q1 | 9.9 billion INR | 30.8 billion INR |
| 2012Q4 | 8.8 billion INR | 28.5 billion INR |
| 2012Q3 | 3.2 billion INR | 26.6 billion INR |
| 2012Q2 | 8.0 billion INR | 26.6 billion INR |
| 2012Q1 | 8.2 billion INR | 23.3 billion INR |
| 2011Q4 | 6.7 billion INR | 21.5 billion INR |
| 2011Q3 | 6.0 billion INR | 18.9 billion INR |
| 2011Q2 | 5.0 billion INR | 16.4 billion INR |
SUNPHARMA.BO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 84.7 billion INR | 432.8 billion INR |
| 2022 | 32.7 billion INR | 384.3 billion INR |
| 2021 | 29.0 billion INR | 331.4 billion INR |
| 2020 | 37.6 billion INR | 323.3 billion INR |
| 2019 | 26.7 billion INR | 286.9 billion INR |
| 2018 | 21.6 billion INR | 260.6 billion INR |
| 2017 | 69.6 billion INR | 299.9 billion INR |
| 2016 | 47.2 billion INR | 277.3 billion INR |
| 2015 | 45.4 billion INR | 272.9 billion INR |
| 2014 | 31.4 billion INR | 160.0 billion INR |
| 2013 | 29.8 billion INR | 112.4 billion INR |
| 2012 | 25.9 billion INR | 80.0 billion INR |
| 2011 | 18.2 billion INR | 57.2 billion INR |
| 2010 | 13.5 billion INR | 39.0 billion INR |
| 2009 | 18.8 billion INR | 42.7 billion INR |
| 2008 | 15.5 billion INR | 33.6 billion INR |
| 2007 | 8.4 billion INR | 21.3 billion INR |
| 2006 | 5.7 billion INR | 16.4 billion INR |
| 2005 | 4.0 billion INR | 12.0 billion INR |
| 2004 | 3.3 billion INR | 9.8 billion INR |
SUNPHARMA.BO
Price: ₹1,530.80
Dividend Yield: 0.01%
Forward Dividend Yield: 1.11%
Payout Ratio: 45.76%
Dividend Per Share: 17.00 INR
Earnings Per Share: 37.05 INR
P/E Ratio: 39.47
Exchange: BSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.6 trillion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 22.72%
DGR5: 30.00%
DGR10: 30.00%
DGR20: 30.00%